FR2703249B1 - Composition pharmaceutique ayant une activité analgésique contenant du naproxène. - Google Patents
Composition pharmaceutique ayant une activité analgésique contenant du naproxène.Info
- Publication number
- FR2703249B1 FR2703249B1 FR9402977A FR9402977A FR2703249B1 FR 2703249 B1 FR2703249 B1 FR 2703249B1 FR 9402977 A FR9402977 A FR 9402977A FR 9402977 A FR9402977 A FR 9402977A FR 2703249 B1 FR2703249 B1 FR 2703249B1
- Authority
- FR
- France
- Prior art keywords
- analgesic activity
- pharmaceutical composition
- activity containing
- containing naproxen
- naproxen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI930582A IT1272149B (it) | 1993-03-26 | 1993-03-26 | Composizione farmeceutiche ad attivita' analgesica |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2703249A1 FR2703249A1 (fr) | 1994-10-07 |
FR2703249B1 true FR2703249B1 (fr) | 1995-07-13 |
Family
ID=11365508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9402977A Expired - Fee Related FR2703249B1 (fr) | 1993-03-26 | 1994-03-15 | Composition pharmaceutique ayant une activité analgésique contenant du naproxène. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5693312A (fr) |
JP (1) | JP3784843B2 (fr) |
BE (1) | BE1006718A3 (fr) |
CA (1) | CA2120048C (fr) |
CH (1) | CH686403A5 (fr) |
DE (1) | DE4410470A1 (fr) |
ES (1) | ES2109131B1 (fr) |
FR (1) | FR2703249B1 (fr) |
GB (1) | GB2276545B (fr) |
IT (1) | IT1272149B (fr) |
NL (1) | NL194390C (fr) |
SE (1) | SE517006C2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1301966B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
GB9924636D0 (en) * | 1999-10-18 | 1999-12-22 | Norgine Bv | Laxative preparation |
US20030235629A1 (en) * | 1999-11-06 | 2003-12-25 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
US6727286B2 (en) | 2001-11-02 | 2004-04-27 | Cumberland Pharmaceuticals Inc. | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
ES2253326T3 (es) * | 2001-11-02 | 2006-06-01 | Cumberland Pharmaceuticals Inc. | Composicion farmaceutica de acido 2-(4-isobutilfenilo)propionico. |
BRPI0409127A (pt) * | 2003-04-11 | 2006-03-28 | Pfizer | combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio |
US20050008699A1 (en) * | 2003-07-11 | 2005-01-13 | Fred Wehling | Effervescent glucosamine composition |
UY28583A1 (es) * | 2003-10-30 | 2005-05-31 | Roche Consumer Health Ag | Forma de presentación del naproxeno sodico |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
EP1905427B1 (fr) | 2006-09-28 | 2010-11-24 | Losan Pharma GmbH | Formulation solubilisée rapidement des anti-inflammatoires non stéroïdiens |
US8828452B2 (en) * | 2007-05-22 | 2014-09-09 | Glenn Abrahmsohn | Method for pain control |
JP2010528040A (ja) * | 2007-05-22 | 2010-08-19 | グレン エイブラムソーン, | 疼痛管理のための方法 |
BRPI0800951A2 (pt) * | 2008-04-09 | 2012-02-22 | Ems Sa | novos compostos derivados de taurina e seus usos, processo de sua preparação e composições farmacêuticas contendo os mesmos |
JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
JP7163015B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 経口固形組成物 |
US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3904682A (en) * | 1967-01-13 | 1975-09-09 | Syntex Corp | 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid |
GB1497044A (en) * | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
US4344929A (en) * | 1980-04-25 | 1982-08-17 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4587249A (en) * | 1982-07-22 | 1986-05-06 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
US5053396A (en) * | 1985-08-27 | 1991-10-01 | Blass David H | Therapeutic composition |
IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
SE463541B (sv) * | 1987-08-31 | 1990-12-10 | Lejus Medical Ab | Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
KR920700613A (ko) * | 1989-05-16 | 1992-08-10 | 지구르트 퓌터 | 약제제 |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
HUT59656A (en) * | 1990-11-15 | 1992-06-29 | Puetter Medice Chem Pharm | Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components |
HUT59692A (en) * | 1990-11-15 | 1992-06-29 | Puetter Medice Chem Pharm | Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars |
-
1993
- 1993-03-26 IT ITMI930582A patent/IT1272149B/it active IP Right Grant
-
1994
- 1994-03-10 CH CH71194A patent/CH686403A5/it not_active IP Right Cessation
- 1994-03-15 FR FR9402977A patent/FR2703249B1/fr not_active Expired - Fee Related
- 1994-03-17 BE BE9400290A patent/BE1006718A3/fr not_active IP Right Cessation
- 1994-03-18 GB GB9405420A patent/GB2276545B/en not_active Expired - Fee Related
- 1994-03-25 DE DE4410470A patent/DE4410470A1/de not_active Withdrawn
- 1994-03-25 ES ES09400644A patent/ES2109131B1/es not_active Expired - Fee Related
- 1994-03-25 CA CA002120048A patent/CA2120048C/fr not_active Expired - Fee Related
- 1994-03-25 NL NL9400481A patent/NL194390C/nl not_active IP Right Cessation
- 1994-03-25 JP JP05571694A patent/JP3784843B2/ja not_active Expired - Fee Related
- 1994-03-25 SE SE9401005A patent/SE517006C2/sv not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/470,143 patent/US5693312A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BE1006718A3 (fr) | 1994-11-22 |
US5693312A (en) | 1997-12-02 |
SE9401005D0 (sv) | 1994-03-25 |
NL9400481A (nl) | 1994-10-17 |
GB2276545B (en) | 1996-08-14 |
FR2703249A1 (fr) | 1994-10-07 |
DE4410470A1 (de) | 1994-09-29 |
ITMI930582A0 (it) | 1993-03-26 |
JPH06321777A (ja) | 1994-11-22 |
GB9405420D0 (en) | 1994-05-04 |
NL194390C (nl) | 2002-03-04 |
JP3784843B2 (ja) | 2006-06-14 |
CA2120048C (fr) | 2004-01-27 |
GB2276545A (en) | 1994-10-05 |
CA2120048A1 (fr) | 1994-09-27 |
SE517006C2 (sv) | 2002-04-02 |
IT1272149B (it) | 1997-06-11 |
ES2109131B1 (es) | 1998-08-16 |
ITMI930582A1 (it) | 1994-09-26 |
SE9401005L (sv) | 1994-09-27 |
NL194390B (nl) | 2001-11-01 |
CH686403A5 (it) | 1996-03-29 |
ES2109131A1 (es) | 1998-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2703249B1 (fr) | Composition pharmaceutique ayant une activité analgésique contenant du naproxène. | |
ATE427925T1 (de) | Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe | |
IT1264855B1 (it) | Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici | |
SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
RU95112575A (ru) | Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
ES2148593T3 (es) | Compuestos retinoides trienoicos novedosos y metodos. | |
ITMI931326A1 (it) | Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico | |
HUP0105280A2 (hu) | Benzaldehidszármazékok és gyógyászati alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE253359T1 (de) | Antithrombotische mittel | |
DE3584608D1 (de) | Amidabkoemmlinge. | |
EA200101241A1 (ru) | Производные индола | |
RU95113437A (ru) | (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью | |
ATE286395T1 (de) | Antithrombotische mittel | |
ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
ATE60787T1 (de) | Pharmakologisch wirksame verbindungen. | |
ITMI913448A1 (it) | Sali stabili dell'acido (+)-(1r, 2s)-2((n-(2-idrossilammino-2-ossoetil) -n-metilammino)carbonil)cicloesan-1-carbossilico, ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
EA200400954A1 (ru) | Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту | |
DE69824410D1 (en) | Antithrombosemittel | |
DK601483D0 (da) | Benzhydrylpiperazinderivater | |
EA199900823A1 (ru) | Ингибиторы протеазы вич | |
IT1184139B (it) | Composti ad attivita' mucolitica e broncodilatatrice,procedimento per la loro preparazione e composizioni farmaceutiche che licontengono come principi attivi | |
AU1434201A (en) | Antithrombotic agents | |
AR037497A1 (es) | Derivado de (r)-n-[2-cloro-4-etilsulfonil-3-(4-piperazin-1il)fenil]-2-hidroxi-2-metil-3,3,3-trifluoropropanamida, composicion farmaceutica, proceso para su preparacion y su uso en la fabricacion de un medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
ST | Notification of lapse |
Effective date: 20091130 |